Team Lottie’s Appeal

£229,612 donated of £155,000 goal

Lottie has been fighting high-risk neuroblastoma since she was 2 ½. A happy little girl with a sweet wilful nature, she loves to create and adores anything pink and sparkly.

Now 4 years old, Lottie has been responding well to frontline standard treatment and is due to finish immunotherapy mid-September 2017. This will mark the end of her treatment in the UK, at which point it is hoped that her end-of-treatment scans will show no evidence of disease.

Then, to keep Lottie in remission and help prevent relapse, which she is more susceptible to because her primary tumour had MYCN markers, her next step will be to access the Bivalent Vaccine clinical trial at Memorial Sloan Kettering Cancer Center, New York. Her family and treating team have identified this as the best option to help keep Lottie neuroblastoma free.

Lottie and her family remain ever positive and prepared to fight and have been appealing for your help to raise £155k to access the trial; cover the associated costs (e.g. travel and accommodation); and to ensure a contingency for any unforeseen complications.

Thanks to the incredible support they’ve received, the family met their fundraising target on 15th September. They now have enough funds in place for Lottie to access the treatment, which pending confirmation of her eligibility, they hope she can do very soon.

“We will never leave her side. We’ll never give up, we’ll fight with her, for her, and next to her.” Lottie’s parents, Charlotte and Dave.

Read more about Lottie’s story

Lottie’s fundraising campaign

Relapse rates for neuroblastoma are high, and the survival rate for relapsed neuroblastoma is less than 10%. This statistic worsens with every relapse. Relapsed neuroblastoma is particularly challenging to treat and there are limited options to treat it; all of which exist in the form of clinical trials, some in the UK and some abroad. Many families, just like Lottie’s, will choose for their child to access these experimental therapies in an attempt to help prevent cancer returning or to get their child back in to remission.

Lottie’s family and treatment team have identified the Bivalent Vaccine clinical trial in New York to try to help keep Lottie’s cancer away. They have raised enough funds to secure Lottie’s access to this treatment and therefore, any additional funds raised will be held for Lottie for a period of 5 years post the end of her treatment in case she needs them.
How you can help

There are many ways you can help Lottie; by making a personal donation; holding a fundraiser; getting sponsored to take on a challenge; or simply following and sharing Lottie’s story through her Facebook and Twitter page.

Download our free Lottie resources (below) to support your fundraising, and click here for even more resources, including fundraising ideas, templates and guidance.

Event Poster Template

Sponsorship Form

To donate by text, send “LOTTIE” followed by any whole amount up to £20 to 70085. This will cost your donation plus your standard network charge. It won’t matter if you leave a space before the number, if you include a ‘£’ sign or whether you use upper or lower case.

If you’d like help supporting Lottie’s campaign, please get in touch with the fundraising team on 0207 284 0800 |

“Lottie is our baby and we won’t lose her. Thank you so much for all of your support for Lottie.” Lottie’s parents, Charlotte and Dave

Terms and Conditions for Appeals

All donations are paid into Solving Kids’ Cancer’s (SKC) general funds to further its general charitable purposes. The funds raised by this Appeal are not restricted for the child’s use. However, the trustees of SKC have agreed to designate 90% of funds raised by this Appeal to help pay for treatment costs and all other associated costs including travel and accommodation. We will use the remaining 10% to pay for Solving Kids’ Cancer’s administrative and fundraising costs.

If: the child no longer needs the funds; the fundraising target is exceeded; insufficient funds are raised to fund the treatment; or if the trustees decide, at their absolute discretion, that the funds should be used for a different purpose, they may redesignate all or part of the 90% for SKC’s general charitable purposes. We are very grateful for your charitable donation.

For further information about SKC and how we spend donations, please contact

Solving Kids' Cancer Europe a registered charity no. 1135601 and registered company no. 7208648.

Join our newsletter

Privacy Policy (click to expand)

Follow Us

Useful links

Contact us

Solving Kids' Cancer

Tel: 020 7284 0800

CAN Mezzanine
49-51 East Road
N1 6AH

Contact us